ArticleFrontiers in molecular biosciences2020

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy.

Yanhua Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.